Home > Policy > Innovation > Nanomaterials > Documents
28 January 2013
Nanotechnologies involve manufacturing and using materials at the smallest scale. These views are those of 15 European industry associations with an interest in nanotechnologies and nanomaterials.
03 October 2012
Following an initial mapping of the potential risks of nanotechnologies in March 2004, several scientific bodies have been working on the risk assessment of nanomaterials.
In their conclusions, there is general recognition that testing strategies and safety assessments currently in place can be used as well for nanomaterials as for any other chemicals. Refinements need to be added, however, to some specific elements such as sampling preparation and dosimetry, and measurement techniques.
Research activities focusing on critical aspects of physico-chemical properties and bioavailability are needed to fine-tune the results of risk assessments of nanomaterials. In the meantime, worst case scenarios can be applied, as usual practice when facing uncertainty of results.
In October 2011, the European Commission adopted the following, general definition of nanomaterials. “A natural, incidental or manufactured material containing particles, in an unbound state or as an aggregate or as an agglomerate and where, for 50 % or more of the particles in the number size distribution, one or more external dimensions is in the size range 1 nm - 100 nm”. These nanomaterials are not intrinsically hazardous. The purpose of the definition is to identify materials for which there may be a need to take into account specific considerations in their risk assessment. The definition will be reviewed in 2014.
1. What are nanomaterials? 2. How do nanomaterials differ from other chemicals?
3. What is nanotechnology? 4. Where are nanomaterials used today?
5. Why do we need innovation in nanomaterials and nanotechnologies?
6. Are nanomaterials safe for human health and the environment?
7. Is the current EU legislation sufficient to regulate nanomaterials?
8. Should there be a label or an inventory for products containing nanomaterials?
9. What voluntary measures are in place to ensure nanomaterials are safe?
17 January 2012
With the help of concrete examples, this document provides guidance on how companies can apply the Responsible Care principles to producing and using nanomaterials.
24 June 2008
European Commission: Introduction to nanotechnologiesNanoforum - European Nanotechnology GatewayNanotechnology Homepage of the European Commission
For more information
Getting responsible chemicals management recognized throughout the entire supply chain is our key objective.
» Learn more about Regulatory Framework
The 2012 Cefic European Facts & Figures provides an analysis of the latest competitive trends in the European chemicals industry.
» Learn more about Facts and Figures
The Responsible Care ethic helps chemical companies to operate safely, profitably and with due care.
» Learn more about Responsible Care